Eric D. Bateman (Cape Town, South Africa), H. Marike Boezen (Groningen, Netherlands)
LATE-BREAKING ABSTRACT: Biomarkers of ECM turnover and clinical relevant outcomes in COPD: Results of the multicenter PROMISE study
Daiana Stolz (Basel, Switzerland), Daiana Stolz, Jacob Hull Kristensen, Diana Julie Leeming, Morten Asser Karsdal, Tobias Welte, Antoni Torres, Renaud Louis, Wim Boersma, Branislava Milenkovic, Konstantinos Kostikas, Francesco Blasi, Joachim Aerts, Gernot Rohde, Alicia Lacoma, Lucas Boeck, Janko Rakic, Andreas Scherr, Michael Tamm
|  |
Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity
Daiana Stolz (Basel, Switzerland), Jyotshna Mandal, Michael Roth, Eleni Papakonstantinou, Michael Tamm, Lucas Boeck, Andreas Scherr, Janko Rakic, Renaud Louis, Branislava Milencovic, Wim Boersma, Konstantinos Kostikas, Francesco Blasi, Joachim Aerts, Gernot Rohde, Alicia Lacoma, Antoni Torres, Tobias Welte, Daiana Stolz
| |
Biological and phenomenological markers of ageing in patients with COPD and their relationship to CT emphysema scores
Rudolf A Jörres (Munich, Germany), Tanja Schramm, Angelika Kronseder, Frank Biertz, Hans-Ulrich Kauczor, Dennis Nowak, Rudolf Maria Huber, Martina Kerscher, Rudolf A. Jörres
| |
Distribution of COPD phenotypes according to the Spanish COPD guidelines in clinical practice
Marc Miravitlles (Barcelona, Spain), Marc Miravitlles, Myriam Calle, Juan Luis Rodríguez, Cristina Murio, On Behalf of the FENEPOC Study Group
|   |
Daily monitoring parameters of arterial stiffness and central aortic pressure in COPD patients comorbid with arterial hypertension
Tatiana Aksenova (Chita, Zabaykalsky Krai, Russian Federation), Tatiana Aksenova, Vladimir Gorbunov, Sergey Lukyanov, Svetlana Tsarenok, Marina Koshkina
| |
Morning and nighttime symptoms in COPD and efficacy of aclidinium/formoterol in symptomatic vs asymptomatic patients
Marc Miravitlles (Barcelona, Spain), Marc Miravitlles, Esther Garcia Gil, Ferran Chuecos, Rosa Lamarca
| |
Patterns of symptom change measured using the EXACT diary associated with prescription of corticosteroids or antibiotics in COPD exacerbations
Stefano Vezzoli (Parma, Italy), Stefano Vezzoli, Paul Jones, Massimo Corradi, Géraldine Cohuet, Dave Singh, Jørgen Vestbo, Jadwiga Wedzicha, Stefano Petruzelli
| |
Prospective phase 1 open clinical trial to study the safety of adipose derived mesenchymal stem cells (ADMSCs) in COPD and combined pulmonary fibrosis and emphysema (CPFE)
Demosthenes Bouros (Athens, Greece), Vassilios Tzilas, Evangelos Bouros, Danae Fourla, Athanasios Zisimopoulos, Nikolaos Papadopoulos, George Koliakos, George Kolios, Ioannis Pneumatikos, Vassilis Aidinis, Agyris Tzouvelekis, Demosthenes Bouros
| |